Biotie Therapies (BITI) Priced

Developing a therapy to extend the efficacy of levodopa for Parkinson's disease.

Health Care - Biotechnology

IPO Performance
Latest Trade $25.80 0.00 (0.0%)
First Day Return 38.4%
Return from IPO 73.3%
 
Biotie Therapies IPO News more
  • .
IPO Data
IPO File Date 05/14/2015
Offer Price $14.89
Price Range $14.82 - $14.82
Offer Shares (mm) 3.8
Deal Size ($mm) 56
 
IPO Data
IPO Date 06/10/2015
Offer Price $14.89
Price Range $14.82 - $14.82
Offer Shares (mm) 3.8
Deal Size ($mm) $56
 
Underwriters
more
Business Overview
Developing a therapy to extend the efficacy of levodopa for Parkinson's disease.
Developing a therapy to extend the efficacy of levodopa for Parkinson's disease.
more
Company Data
Headquarters Turku, , Finland
Founded 1998
Employees 40
Website www.biotie.com
 

Performance vs. IPO Index (IPOUSA)